Redefining Inspection Readiness: Quality in the Age of Transparency
Be Audit-Ready, Every Day
Learn what FDA’s new transparency data reveals about inspection readiness and how proactive quality cultures are adapting
The FDA’s public CRL database exposes recurring inspection-related findings — from missing CAPA documentation to incomplete audit trails. This whitepaper explores what those trends mean for quality teams, and how to embed continuous readiness into daily operations.